
Review article
Select search scope: search across all journals or within the current journal

Provision of enteral nutrition (EN) to critically ill patients early upon admission to the intensive care unit exerts a beneficial physiologic effect that downregulates systemic immune responses, reduces oxidative stress, and improves patient outcome. Adding specific pharmaconutrient agents to EN in certain patient populations has a synergistic effect, magnifying the degree of this favorable physiologic response. In contrast, failure to provide enteral nutrients creates a physiologic profile that exacerbates oxidative stress and increases the systemic inflammatory response syndrome. Unfortunately, parenteral nutrition (PN) in the form and manner currently provided in North America does not appear to mimic the same physiologic response seen with EN. In the future, use of alternative fuel sources, steps to promote better tolerance of EN, and innovative strategies for delivery of both EN and PN may serve to further enhance the physiologic effect of nutrition therapy and to achieve even greater improvement in patient outcome.
Those who read the medical literature should understand the principles of evidence-based medicine. Even randomized trials can contain design or interpretative flaws that allow bias to produce, or exaggerate the size of, beneficial effects. Such problems beset the literature of enteral nutrition (EN). Investigators who have compared EN with parenteral nutrition (PN) have alleged that EN produces fewer adverse events, but such studies do not assess the absolute value of either therapy, and data exist suggesting that PN causes net harm. Trials comparing EN with no nutrition therapy have not yielded convincing evidence of efficacy because the study designs have failed to use methods to prevent bias from interfering with the observations. This same problem exists with trials that have assessed volitional feeding programs (eg, oral supplements). Thus, although systematic reviews have alleged that EN benefits patients undergoing surgery, patients in the critical care unit, patients with liver disease, and patients with pancreatitis, the presence of bias limits any positive conclusions. As a manifestation of this issue, when the various trials are separated into studies with high and low risks of bias, those with low risks have not shown any benefit. EN has been accepted and implemented despite the lack of convincing scientific support of efficacy.
Enteral misconnections are defined as inadvertent connections between enteral feeding systems and nonenteral systems such as intravascular lines, peritoneal dialysis catheters, tracheostomy tube cuffs, medical gas tubing, and so on. Sentinel event data and causative factors are outlined along with potential solutions to prevent such medical errors. The solutions can be grouped into 3 areas: (1) education, awareness, and human factors; (2) purchasing strategies; and (3) design changes. Updates on safety innovations and programs are presented.
In developing the evidence-based
In the last few decades, there has been tremendous advancement in the area of enteral nutrition formulas. Enteral nutrition makes it possible to provide important substrates for those who cannot or will not meet daily requirements via oral intake but who have an intact digestive system. Numerous enteral nutrition formulas are currently available, with a large portion of them targeting specific disease conditions, thus making it a daunting task at times for a clinician to sort through all the possibilities and decide on the most appropriate formula. This review provides a close examination of various enteral formula categories and presents proposed mechanisms of specialized ingredients, followed by a thorough evidence-based analysis of existing literature before making recommendations for the various enteral formula categories.
Because every child has individual needs, there are a variety of infant and pediatric formulas from which to choose. Not only are there several categories of formulas including milk protein-based, soy protein-based, hydrolyzed protein, and amino acid-based, but there are differences between products within each category. Research is being done in the area of formula design for the prevention or treatment of disease. In this article, the authors review types of formulas and their indications for use for infants and children, and review current literature on formula trends.
The delivery of a preterm baby is a nutrition emergency. Growth and the accumulation of nutrient reserves are higher during the third trimester of pregnancy than at any other time during the life cycle. Enteral nutrition is the preferred mode of support and human milk the preferred source of enteral nutrition. Human milk is highly digestible and contains many anti-infective components, which confer a lower risk of infection. The mother of a preterm infant requires education, equipment, and encouragement to successfully initiate and sustain lactation. Human milk requires nutrient fortification to meet the protein and mineral needs of the rapidly growing preterm infant. Commercial human milk fortifiers are available. If human milk is unavailable or the volume is insufficient, preterm formulas are available. Preterm formulas have different sources of macronutrients and greater density of all nutrients than formulas intended for term newborns. Preterm infants benefit from early enteral feedings with slow but steady increases in feedings to achieve full support. Infants born at <35 weeks gestational age are supported with tube feedings. A transition to feedings at the breast or to bottle feedings is gradually made as the baby matures. Nutrient recommendations specific to the preterm infant are available. Special products and feeding strategies exist to respond to common medical conditions that can complicate nutrition management. Optimal nutrition care of the preterm infant offers the opportunity to improve outcomes for children.
The pediatric intensive care unit (PICU) environment poses unique challenges to achieving enteral nutrition (EN) goals for the critically ill child. Nutrition support in the PICU is often in conflict with the complexity of care provided to acutely ill children. A significant proportion of eligible patients do not receive optimal enteral nutrition for avoidable reasons. Early institution of EN is recommended and the gastric route is preferred because of ease of administration and reduced costs compared with the transpyloric route. In patients with poor gastric emptying or in cases where a trial of gastric feeding has failed, transpyloric or postpyloric feeding may be used to decrease the risk of aspiration and to improve enteral feed tolerance. However, there is no evidence of benefit for routine use of small bowel feeding in all patients admitted to the PICU. The placement of blind nasoenteric feeding tubes can be technically challenging, is not without complications, and requires local expertise and experience for successful placement and maintenance. A protocolized approach to selecting the optimal route and advancing enteral feedings may optimize EN delivery. Institutional practice guidelines based on consensus, available evidence, and national guidelines may decrease time to reaching caloric goal, improve protein balance, and potentially affect clinical outcomes. The rationale and challenges to the delivery and maintenance of optimal EN, and strategies to achieve optimal EN during critical illness, are discussed.
The risk for disordered oropharyngeal swallowing (dysphagia) increases with
age. Loss of swallowing function can have devastating health implications,
including dehydration, malnutrition, pneumonia, and reduced quality of life.
Age-related changes increase risk for dysphagia. First, natural, healthy aging
takes its toll on head and neck anatomy and physiologic and neural mechanisms
underpinning swallowing function. This progression of change contributes to
alterations in the swallowing in healthy older adults and is termed